Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors
Carbonic anhydrase isoenzymes I and II (hCAI and hCAII) inhibitory properties of novel sulfamides were investigated. These compounds showed promising inhibitory effects. Sulfamides represent an important class of biologically active compounds. A series of novel sulfamides were synthesized from 1-ami...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2013-03, Vol.21 (6), p.1379-1385 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Carbonic anhydrase isoenzymes I and II (hCAI and hCAII) inhibitory properties of novel sulfamides were investigated. These compounds showed promising inhibitory effects.
Sulfamides represent an important class of biologically active compounds. A series of novel sulfamides were synthesized from 1-aminoindanes, 1-aminotetralin, 2-aminoindanes and 2-aminotetralin via the reactions of free amines, benzyl alcohol and chlorosulfonyl isocyanate (CSI) followed by hydrogenolysis of the obtained sulfamoylcarbamates. Carbonic anhydrase (CA, EC 4.2.1.1) inhibitory effects of the new sulfamides have been investigated. The human (h) isozymes hCA I and hCA II have been investigated in this study by using an esterase assay with 4-nitrophenyl acetate as substrate. The new sulfamides showed inhibition constants in the micro–submicromolar range, with one compound (N-(indane-1-yl)sulfamide) showing a Ki of 0.45μM against hCA I and of 1.07μM against hCA II. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2013.01.019 |